Drug-Resistant, Epilepsy

Drug-Resistant Epilepsy Market to Accelerate With Significant CAGR by 2036 as Demand for Advanced Therapies Increases | DelveInsight

Veröffentlicht: 20.03.2026 um 00:06 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom

en | CA00765C1086 | DRUG-RESISTANT | boerse | 68911249 |